Once-weekly semaglutide in adolescents with obesity

Weghuber, Daniel, Barrett, Timothy, Barrientos-Pérez, Margarita, Gies, Inge, Hesse, Dan, Jeppesen, Ole K., Kelly, Aaron S., Mastrandrea, Lucy D. +2 more·2022·New England Journal of Medicine

Cited by (794)

Items 401–500 of 794

  1. Medikamentöse Adipositastherapie in Deutschland
    Matthias Blüher · 2025 · Die Innere Medizin
  2. Neuroprotective and cognitive benefits of Semaglutide: Insights into the underlying molecular mechanisms
    Shayan Yaghmayee, Atefeh Sadat Moazzeni, Tannaz Jamialahmadi, Sercan Karav, Habib Yaribeygi, Prashant Kesharwani, Amirhossein Sahebkar · 2025 · Neuroscience
  3. Mechanisms of glucagon-like-peptide 1 in the brain beyond metabolic effects
    Kyu Sik Kim, Joon Seok Park, Hyung Jin Choi · 2025 · Annals of Pediatric Endocrinology & Metabolism
  4. The Role of Endoscopy in the Management of Adolescent Bariatric Patients: A Primer For Pediatric Gastroenterologists
    Robert E Kramer · 2023 · Current Gastroenterology Reports
  5. Pharmacotherapy of Obesity and Metabolic Syndrome
    Daisy Duan, Rexford S. Ahima · 2023 · Springer eBooks
  6. Interventions for Children and Adolescents With High Body Mass Index—Implementing the Recommendations in Clinical Practice
    Roohi Y. Kharofa, Nancy Abigail Crimmins, AMY SANGHAVI SHAH · 2024 · JAMA Network Open
  7. The effect of parental weight and genetics on the body mass index of very low birth weight infants as they reach school age
    Wolfgang Göpel, Carla Lüders, Katharina Heinze, Tanja Katrin Rausch, Mats Ingmar Fortmann, Silke Szymczak, Inke Regina König, Egbert Herting, Kathrin Hanke · 2025 · Deutsches Ärzteblatt international
  8. Body Mass Index and Right Ventricular Structure: Insights From Observational and Mendelian Randomization Analyses
    Julian Pott, Maximilian Kirchner, Jan K. Hennigs, Christoph Sinning, Hans F. E. Klose, Lars Harbaum · 2025 · Pulmonary Circulation
  9. Case Series of Nizon‐Isidor Syndrome by Heterozygous Variants in MED12L With Further Evidence of Mitotic Instability in One Case With Diploid–Triploid Mosaicism
    Russell Stewart, Kimberly M. Ezell, Deanna S. Bell, Brian Corner, Ashley McMinn, Joy D. Cogan, Rizwan Hamid, Lynette C. Rives, John A. Phillips, Nina U. Paddu et al. · 2025 · American Journal of Medical Genetics Part A
  10. Unanticipated Residual Gastric Contents in an Appropriately Fasted Pediatric Patient on Glucagon-Like Peptide-1 Receptor Agonist Therapy: A Case Report and Review of Perioperative Considerations
    Max Lookabaugh, Kim M. Strupp, Leah Margalit Winters Webb · 2025 · Cureus
  11. Pediatric MASLD: The New Era Practical Approach to Assessment and Treatment of Pediatric MASLD with Emphasis on Risk Factors and Obesity Medications
    Dieudonne Nonga, Eileen A. Chaves, Sindhu Pandurangi, Kayla T. Hartjes, Christopher Chu, Alvaro Flores · 2025 · Current Treatment Options in Pediatrics
  12. Cardiovascular Disease and Diabetes: A New Challenge in the Treatment and Management
    Graziano Riccioni, Chiara Notarangelo, Mario Riccioni, Nicolantonio D’Orazio · 2025 · International Journal of Molecular Sciences
  13. Effectiveness of Bariatric Surgery Versus Nutritional Interventions in Adolescents: A Retrospective Cohort Study
    Miri Mizrahi Reuveni, Bar Cohen, Dor Atias, Ilan Yehoshua, Shelley A. Sternberg, Eduardo Schejter, Zorian Radomyslsky, Yakov Segal, Limor Tal Pony, Galit Kowen Sandbank et al. · 2026 · Obesity Surgery
  14. Lifespan approaches for the prevention and management of steatotic liver disease
    Shira Zelber‐Sagi, Dana Ivancovsky-Wajcman, Carina Kugelmas, Ali A. Weinstein, Vincent Wai‐Sun Wong, Laurent Castéra, J. Bernadette Moore, Marialena Mouzaki, Kate Hallsworth, James M. Paik et al. · 2026 · Nature Reviews Gastroenterology & Hepatology
  15. Albuminuria trajectories following intensive lifestyle intervention with or without bariatric surgery in adolescents with and at risk of type 2 diabetes
    Kanchana Perera, JOHN BAKER, Kate Smallman, Karen Pickering, Patricia Harry, Diana Anderson, Brandon Orr‐Walker, Richard Babor, David S Simmons · 2026 · Diabetes Research and Clinical Practice
  16. Metabolic Dysfunction-Associated Steatotic Liver Disease and Incretin Receptor Agonists: A Metabolic Approach to Halting Liver Disease Progression
    Ludovico Abenavoli, Anna Giulia Loricchio, Ivo Lopez, Domenico Morano, Abdulrahman Ismaiel, Dan Lucian Dumitrascu, Francesco Luzza · 2026 · Medicina
  17. A 10-Year Cost-Effectiveness Analysis of Metabolic and Bariatric Surgery in Adolescents
    John B. Rode, Francesca Lim, Todd M. Jenkins, Justin R. Ryder, Thomas H. Inge, Chin Hur, Michael A. Helmrath, Anita P. Courcoulas, Marc P. Michalsky, Stephanie R. Sisley et al. · 2026 · JAMA Network Open
  18. Effect of weight loss interventions on liver-related health in children and adolescents with obesity: a systematic review and meta-analyses
    Alexis Couret, Duane Beraud, Gabriel Torbahn, Julia Lischka, Valérie Julian, Bruno Pereira, James A. King, Armand Abergel, Daniel Weghuber, David Thivel et al. · 2026 · International Journal of Obesity
  19. Pediatric Metabolic Syndrome Through the Lens of Cardiovascular-Kidney-Metabolic Syndrome: A Scoping Review of Definitions, Epidemiology, Outcomes, and Conceptual Implications for Children and Adolescents
    Marissa Montandon, Bettina Mittendorfer, Samar Ibrahim, C. Anwar A. Chahal, Amy Braddock, Fares Alahdab · 2026 · Current Epidemiology Reports
  20. One-year weight loss and metabolic outcomes after laparoscopic sleeve gastrectomy in adolescents compared with young adults: A propensity score-matched cohort study
    Ahmed Taki‐Eldin, Ahmed Lotfy, Mohamed El-Soudani, Mahmoud Abuelyazeed Ghaly, Mohamed Mahmoud Eltaweel, Eslam Taha Ghalwash, Tamer Elalfy, Ahmed M. Kandel, Zakaria M. Abdel Sadek, Ahmed Naji Ahmed · 2026 · Obesity Pillars
  21. EFICÁCIA E SEGURANÇA DOS ANÁLOGOS DO GLP-1 NO TRATAMENTO DA OBESIDADE EM ADOLESCENTES: REVISÃO INTEGRATIVA
    Rayllane Santos Nunes, Rayanne Izabel Maciel de Sousa, Valdetrudes Júnior Holanda dos Santos, Júlia Alves Bandeira Neta, Ítalo Bruno Feitosa Coutinho Braga, Natália Bitú Pinto · 2023 · Temas em Saúde
  22. Preventive cardiology in pediatrics. A fellow's voice
    Hannah Hollon · 2023 · American Journal of Preventive Cardiology
  23. Highlights in the clinical nutrition literature: A critical appraisal of current research
    Stoppe, Christian, Elke, Gunnar, Silvstre, Simone Chaves de Miranda, Kappus, Matthew · 2024 · Journal of Parenteral and Enteral Nutrition
  24. Pediatric Obesity
    Crystal Stack Lim, Shanda W. Sandridge · 2024 · Advances in Psychiatry and Behavioral Health
  25. Semaglutide: effects on eating behavior
    V. V. Gorban, Karen Arzumanyan, M. Yu. Kostyulina, D. A. Mikhaylenko, I. S. Khvostikova, E. D. Shkorkina · 2024 · Meditsinskiy sovet = Medical Council
  26. Obesity Management in Youth with Duchenne Muscular Dystrophy: A Review of Metformin and Alternative Pharmacotherapies
    Victoria E. Goldman, Anna Ryabets‐Lienhard, Lauren E. Howard, Roshni Kohli, Emily Sousa, Priya Patel, Ian Marpuri, Alaina P. Vidmar · 2024 · Childhood Obesity
  27. GLP-1 and GIP analogues in the treatment of obesity
    Agata Jasińska-Balwierz, Radosław Jerzy Balwierz, Paweł Biernat, Natalina Makieieva, Marek Tomków, Klaudia Cesarz, Marcin Osowski, Bartłomiej Dorożyński, Urszula Skotnicka-Graca, Jacek Lipok · 2024 · Pediatria i Medycyna Rodzinna
  28. Adopting national recommendations for clinical management of pediatric obesity in primary care
    Natalia Davila, Julia Garcia, Marcelaine G. Reneau, Whitney Smith · 2025 · The Nurse Practitioner
  29. A Systemic Review of Pharmacological Management of Pediatric Obesity
    Surendra Kumar Gupta · 2025 · Journal of Pharmacy And Bioallied Sciences
  30. Childhood obesity: tackling the social divide
    Eoin Fitzgerald, Órla Walsh, John Fitzsimons · 2025 · Pediatric Research
  31. Calcium/Calmodulin‐Dependent Protein Kinase II Inhibitors Mitigate High‐Fat Diet–Induced Obesity in Mice
    Naoyuki Kawao, Ryosuke Satoh, Yuya Mizukami, Katsumi Okumoto, Genzoh Tanabe, Osamu Muraoka, Reiko Sugiura, Hiroshi Kaji · 2025 · Journal of Obesity
  32. Type 2 Diabetes in a 4-Year-Old With Obesity: Considerations for Use of Semaglutide and Bariatric Surgery in Children
    James Connard, Armine Simonian, Roshanak Monzavi, Kamran Samakar, Alaina P. Vidmar · 2025 · JCEM Case Reports
  33. Glucagon-Like Peptide-1-Receptor Agonist Treatment of Obesity: Is It Cost-Effective and Equitable?
    Lauren Hertzer, Robert Siegel · 2025 · The Journal of Pediatrics
  34. Informed Decision-Making for Glucagon-like Peptide-1 Receptor Agonists Use in Adolescents: A Call for Robust Evidence Related to Healthy Growth and Development
    Jessica L Caouette, Leslie Ann Soyka, Stephenie C. Lemon, Melissa Goulding · 2025 · Journal of Adolescent Health
  35. Semaglutide and weight management in the Arab countries: Focus on the United Arab Emirates
    Sabina Semiz · 2025 · Health Sciences Review
  36. Plasma Metabolomic and Proteomic Signatures of Blood Pressure Management After Bariatric Surgery Among Adolescents
    Shudi Pan, Zhenjiang Li, Juan Pablo Lewinger, Jesse A. Goodrich, H. Wang, Sarah Rock, Carmen Chen, Todd M. Jenkins, Stephanie R. Sisley, Stephen R. Daniels et al. · 2025 · Hypertension
  37. Are Glucagon-Like Peptide 1 Receptor Agonists and Bariatric Surgery the Answer to Childhood Obesity?
    Seema Kumar, Ole Olson, Todd Andrew Kellogg · 2025 · Current Atherosclerosis Reports
  38. The impact of preoperative antiobesity medications on weight loss in adolescents undergoing metabolic and bariatric surgery – a COSMIC study
    Justine O. Chinn, Mark Shacker, Kelly Brennan, Michael A. Kochis, Alyssa E. Stetson, Christa Bizimana, Josélio Rodrigues de Oliveira Filho, Matthew A. Hornick, Janey S.A. Pratt, Marwa Abu El Haija et al. · 2025 · Surgery for Obesity and Related Diseases
  39. Impact of preoperative and postoperative anti-obesity medications on early postoperative body mass index reduction after sleeve gastrectomy in pediatrics
    Alaina P. Vidmar, My H. Vu, Matthew Jeffrey Martin, Aimee G. Kim, Stuart A. Abel, Harry J. Wong, Kamran Samakar · 2025 · Surgery for Obesity and Related Diseases
  40. Idiopathic Intracranial Hypertension in Children and Adolescents with Obesity: A Narrative Review
    Nicola Improda, Giada Ballarin, Selvaggia Lenta, Laura D’Acunto, Celeste Tucci, Marta Giovengo, Claudia Mandato, Antonio Varone, Maria Rosaria Licenziati · 2025 · Children
  41. Evaluation and Management of Polycystic Ovarian Syndrome (PCOS) in Adolescents With Obesity: A Scoping Review of National and International Obesity and PCOS Management Guidelines
    Carey Yun Shan Lim, Kah Yin Loke, Sajini Mary Varughese, Yung Seng Lee, Nicholas Beng Hui Ng · 2025 · Obesity Reviews
  42. Clinical Outcomes Associated with the Use of a Family-Based Digital Support Program in Patients with Pharmacologic Treatment for Obesity
    Antonio de Arriba Muñoz, Oscar Eduardo Rodríguez Montes, Ana R. Conde-Moro, María Teresa García Castellanos, José Andrés Martínez García, Luis Fernández-Luque · 2025 · Journal of Clinical Medicine
  43. Tackling the epidemic of obesity and hypertension in children and young people
    Emily Haseler, Manish D. Sinha · 2026 · Current Opinion in Nephrology & Hypertension
  44. The Ethics of Wegovy in Pediatric Mental Health
    Nanette Ryan, Julian Savulescu · 2026 · Bioethics
  45. Glucagon-like peptide-1 agonists in children with obesity and type 2 diabetes. an umbrella review
    Hyder Othman Mirghani, Laila Ahmed Albishi, Sawsan Mohammed Alblewi · 2026 · Frontiers in Endocrinology
  46. Effectiveness and safety of once-weekly semaglutide for weight loss in adults with overweight or obesity: a systematic review of randomized controlled trials
    Snehashis Singha, Rajasree Majumder · 2026 · International Journal of Basic & Clinical Pharmacology
  47. Laparoscopic Sleeve Gastrectomy for Adolescents With Severe Obesity: Medium‐Term Weight Outcomes and Mental Health Insights
    John Peacey, Shiyen Lim, George Hopkins, Christine E. Skinner · 2026 · ANZ Journal of Surgery
  48. Characteristics of Youth Treated With GLP-1RAs at an Integrated Weight Management Clinic
    Emily F. Gregory, Rachana D. Shah, Jeremy J. Michel, Zia H. Huballah, Nia A. Frederick, Deepthi Gunturi, Emma K. Edmondson · 2026 · PEDIATRICS
  49. “Rewiring the hypothalamus: emerging neuroendocrine and neurotechnological approaches to obesity”
    Gaurav Tiwari, Anand B. Mundada, Pooja Anand Mundada, Dr Rakhee Oza Prof. Neha Maheshwari, Shivani Singh, Rajeev Kumar, Hanish Singh Jayasingh Chellammal, Pankaj Sharma · 2026 · Biological Rhythm Research
  50. iCARDIO Alliance Global Implementation Guidelines for the Management of Obesity: Focus on Prevention and Treatment of Cardiometabolic Disease
    Stefan D. Anker, Linong Ji, Tammy Lyn Kindel, Andrew J.S. Coats, Dike Bevis Ojji, Adriana Puente-Barragán, Peter R Rossing, Shelley R. Zieroth, Shaaf Ahmad, Shariq Usman et al. · 2026 · Journal of the Association of Physicians of India
  51. Efficacy and safety of glucagon-like peptide-1 (GLP-1) agonists in pediatric obesity: A systematic review and meta-analysis
    Ghassan Sukkar, Mumen H. Halabi, Yousef H. Faden · 2026 · Saudi Journal of Gastroenterology
  52. Efficacy and safety of GLP-1 receptor agonists for adolescents and children with obesity: a meta-analysis of randomized controlled trials
    Qirong Chen, Haixia Liu, Jie Xu, Yu Zhou, Junying Ma · 2026 · BMC Endocrine Disorders
  53. Metabolic Flux Adaptations During GLP-1 Receptor Agonist Therapy: Redox Implications
    Jaewang Lee, Ji Hyeon You, Hyun Jin Park, Jong-Lyel Roh, Sun Ha Paek · 2026 · Current Obesity Reports
  54. GZR18, a GLP-1 analog with once-weekly or bi-weekly dosing for body weight management: A randomized, placebo-controlled, phase 1b/2a trial
    Linong Ji, Leili Gao, Ruihua Dong, Mingxia Yuan, Dong Zhao, Shuguang Pang, Jing Zhao, Liyuan Zhao, Wei Chen · 2026 · Cell Reports Medicine
  55. Childhood Obesity, Medications, and Surgeries
    Srinidhi Raghav, William H. Frishman · 2026 · Cardiology in Review
  56. Dynamics of Body Composition and Metabolic Risk in Adolescents With Obesity Under GLP ‐1 Receptor Agonist Therapy
    Adar Lopez, Liat Perl, Eyal Cohen‐Sela, Ophir Borger, Yael Issan, Hagar Interator, Erez Azoulay, Hadar Moran‐Lev, Ronit Lubetzky, Shira Zelber‐Sagi et al. · 2026 · Acta Paediatrica
  57. GLP ‐1 Receptor Agonists and Psychiatric Outcomes in Adolescents: A Systematic Review and Meta‐Analysis
    Cynthia F. X. C. A. Silva, Bruno Lins de Souza, Gianlucca Thomazini, Jardeson Júnior, Oscar Inácio de Mendonça Bisneto, Izabella De Abreu, Túlio Konstantyner, Marconi Abreu · 2026 · Diabetes Obesity and Metabolism
  58. Converging neurotrophic-immune signaling in autism spectrum disorder: integrative roles of klotho, GDNF/GFRA-1, IGF-1 and GLP-1 pathways
    Janvi Verma, Rohit Kumar Singh, Supratim Paul, Sumedha Gupta, Abhishek Kumar Gupta, Arun Kumar Sharma, Manjeet Kumar, Sidharth Mehan, Rajaram Samant, Manoj Tongra · 2026 · Metabolic Brain Disease
  59. Cost-Effectiveness of Access to Obesity Care and Treatments for Adolescents
    Tran T. Doan, Heeseung J. Mueller, Anton L.V. Avanceña, Vaishnavi Peyyety, Megan O. Bensignor, Mary Ellen Vajravelu · 2026 · Childhood Obesity
  60. Use of Glucagon‐Like Peptide‐1 Receptor Agonists in Danish Adolescents and Young Adults 2018–2025
    Helene Kildegaard, Jacob Harbo Andersen, Rebecca Vinding, Julie Tonsgaard Kloppenborg, Anton Pottegård · 2026 · Obesity
  61. Evidence-informed guidance for the clinical use of oral semaglutide in obesity management
    Domenica Rubino, Sean Wharton, Michael G. Knight, Vanita R. Aroda · 2026 · Postgraduate Medicine
  62. Efficacy and safety of semaglutide for obesity and hyperphagia in adults with Prader-Willi syndrome
    Ahmed Shahd, Nicola Bridges, Anthony Peter Goldstone · 2026 · Frontiers in Endocrinology
  63. Intersection of Pediatric Hypertension and Cardiovascular-Kidney-Metabolic Disease
    Jessica O’Keeffe, Christina Kingshill, Jack Tompson, Andrew Michael South, Carissa Marrie Baker-Smith · 2026 · Current Hypertension Reports
  64. Efficacy and tolerance of GLP-1 analogues in the treatment of adolescent obesity: analysis of a French population
    Sarah Bouhmouch, Béatrice Dubern, Catherine Terraz, Patrick Tounian · 2026 · Archives de Pédiatrie
  65. Body Composition Changes During GLP-1 Receptor Agonist Therapy in Pediatric Obesity: A Pilot Study
    Bogdan Mihai Pascu, Irina Bojoga, A. Balanescu, Paul Cristian Balanescu, Ioan Gherghina · 2026 · Metabolites
  66. GLP-1 receptor agonist therapy in children and adolescents with obesity: A network meta-analysis of differential cardiometabolic efficacy and safety profiles
    Y C Li, Xiaoou Xu, Adili Tuersun, Xichen Fan, Muting Qin, Xin Zhao, Subinuer Abuduaini, Haoyue Xing, Huanxue Chen · 2026 · Pharmacological Research
  67. Correlates of Obesity Medication Use in Paediatric Weight Management Programmes: A POWER Consortium Analysis
    Amy L. Christison, Roy Kim, Eileen C. King, Rashmi Sahay, Roohi Y. Kharofa, Brooke R. Sweeney, Vidhu Thaker, Jared M. Tucker, Alaina P. Vidmar, Jennifer K. Yee et al. · 2026 · Pediatric Obesity
  68. Semaglutide Exposure During Pregnancy: Results from the FAERS Database
    Alessia Zinzi, Mario Gaio, Annamaria Mascolo, Gorizio Pieretti, Mattia Cipriani, Joao Marcos Della Ragione, Rossana D’Amato, Francesco Rossi, Annalisa Capuano, Rosanna Ruggiero · 2026 · Pharmaceuticals
  69. Case Report: Acute biliary pancreatitis after semaglutide dose escalation in an adolescent with obesity and cholelithiasis
    Abdalrhman Hamdan Alanizi, Ghadeer M. Alruwythi, Norah H. Alotaibi, Noof H. Alanazi, Amirah M. Alghurabi, Reem Qubaiban, Nawal Alsubaie · 2026 · Frontiers in Pediatrics
  70. Glucagon‐like peptide‐1 therapy for youth with type 2 diabetes
    Young Min Cho · 2022 · Journal of Diabetes Investigation
  71. Obesity Metabolic Phenotypes and Unplanned Readmission Risk in Diabetic Kidney Disease: An Observational Study from the Nationwide Readmission Database
    Wei Zhang, Jing Du, Hang Dong, Yiping Cheng, Fang Zhong, Zinuo Yuan, Yingchun Dong, Rong Wang, Shumin Mu, Jiajun Zhao et al. · 2023 · Archives of Medical Research
  72. Changes in body mass index and behavioral health among adolescents in military families during the COVID-19 pandemic: a retrospective cohort study
    Tracey Pérez Koehlmoos, Cathaleen Madsen, Amanda L. Banaag, Terry A. Adirim · 2023 · BMC Public Health
  73. Pharmacological Strategies for Pediatric Obesity
    Claudia K. Fox, Sarah J. Raatz, Brooke R. Sweeney · 2023 · Springer eBooks
  74. CONSUMO DE PREBIÓTICOS, PROBIÓTICOS E TERAPIA FAMACOLÓGICA E SUA RELAÇÃO COM A MODULAÇÃO INTESTINAL NO TRATAMENTO DA OBESIDADE: UMA REVISÃO DA LITERATURA
    Gabriela Cristina Uebel, Diene da Silva Schlickmann, Munithele Moraes Eisenhardt, Jane Dagmar Pollo Renner, Adriana Simon Coitinho · 2023 · Revista Contemporânea
  75. Pharmakotherapie der Adipositas
    Pia Roser · 2024 · Die Diabetologie
  76. Adipositas im Kindes- und Jugendalter
    Eric Göpel, Antje Körner · 2024 · Die Diabetologie
  77. Low-Value Care for Hospitalized Children With Dual Medical and Behavioral Complexity
    Lyubina Yankova, Adam K. Berkwitt, Jaspreet Loyal · 2024 · Hospital Pediatrics
  78. Rethinking Behavioral Interventions for Adolescent Obesity
    Aaron E. Carroll · 2024 · Archives of Pediatrics and Adolescent Medicine
  79. Second Generation Anti-Obesity Medications
    Sri Nikhita Chimatapu, Steven D. Mittelman, Vibha Singhal · 2024 · Current Pediatrics Reports
  80. NICE guideline review: type 2 diabetes in children and young people – diagnosis and management (NG18)
    Isabella Weber, Benjamin G. Fisher, Cliodhna Myles, Emile Hendriks, Maria Loredana Marcovecchio · 2024 · Archives of Disease in Childhood Education & Practice
  81. Ozempic® e recomendações clínicas atuais para o tratamento da obesidade e controle de peso: uma revisão sistemática
    Leidiany Souza Silva, Ana Laura Rodrigues de Sá, Émery Fernandes Bento Morais, Janaína Pereira Silva, Náthaly Segger Ferreira Barros, Paula Georgia Oliveira Lima, Pricilla Amorim Padilha · 2024 · Revista Cereus
  82. Vantagens da utilização da semaglutida no tratamento de obesidade e sobrepeso - Uma revisão de literatura
    Emanuelle Luisa Fiorese, José Roberto Alves Filho · 2024 · Research Society and Development
  83. Pharmacologic Management of Obesity in Neuro-Oncology: A Case Report
    Alexandra Lardieri, Vidhu Thaker, Kate Citron-Zafrin, James H. Garvin, Stergios Zacharoulis, Elena J. Ladas · 2024 · Case Reports in Oncology
  84. Hormonal Crossroads in Inborn Errors of the Metabolism Impact of Puberty and Dietary Interventions on Metabolic Health
    Thomas Lundqvist, Rasmus Stenlid, Maria Halldin · 2025 · Metabolites
  85. Obesity Management in Female Adolescents
    Lauryn P. Roth, Angelina Valladares Bernier, Lauren D. Gulley, Kristen Lohse, Rachel Whooten, Leora Allen, Heidi Vanden Brink, Joelle Sfeir, Stacey L. Simon, Erin Finn et al. · 2025 · Clinical Endocrinology
  86. Utilizing Semaglutide for Addressing Type-2 Diabetes and Obesity
    Raghav Gupta, Shivani Sharma · 2025 · Current Signal Transduction Therapy
  87. Obesidad y diabetes mellitus tipo 2: tratamiento farmacológico
    Gabriel Ángel Martos‐Moreno, Jesús Argente Oliver · 2025 · Pediatría Integral
  88. Use of obesity medications in a young pediatric patient with optic nerve hypoplasia and severe early-onset obesity: A case report
    Armine Simonian, Emily Sousa, Kamran Samakar, Alaina P. Vidmar · 2025 · Obesity Pillars
  89. Comparative analysis of pharmacokinetic parameters, bioequivalence, safety, tolerability and immunogenicity of semaglutide-based drug for the treatment of obesity
    Ametov As, Petr A. Beliy, K. Ya. Zaslavskaya, E. A. Rogozhina, V. S. Shcherbakova, Yu. G. Kazaishvili, А. В. Таганов, Бодрова Татьяна Геннадьевна, E. S. Mishchenko, Ksenia N. Koryanova et al. · 2025 · Pharmacy & Pharmacology
  90. New directions in childhood obesity treatment – A path forward or wishful thinking?
    Jessica L. Reilly, Shruthi Arora, Kelsey Chatman, Zenobia Cooper, Daniel S. Hsia · 2025 · Journal of clinical lipidology
  91. Post‐Transplant Metabolic Syndrome in Pediatric Liver Transplant Recipients—Contributors, Screening, and Management
    Maarten Buytaert, Eline Braekman, Kaat Van Overbeke, Agnieszka Prytula-Ebels, Pauline De Bruyne, Kathleen De Waele, Kristof Vandekerckhove, Sander Lefere, Ruth De Bruyne · 2025 · Pediatric Transplantation
  92. Binge-Eating Disorder and Obesity in Adolescents: A Review of Behavioral and Pharmacological Treatment Advances
    Sarah E. Hornack, Susma Shanti Vaidya, Jonathan D Chevinsky, Ryan Joy O’Connor, Finza Latif · 2025 · Psychiatric Annals
  93. Treatment of an Adolescent Female With Nonalcoholic Steatohepatitis–Related Cirrhosis With Liraglutide
    Christina Yuen, Tiffany T. Yu, Samuel William French, Elizabeth A. Marcus, Joanna Yeh, Harvey Kenn Chiu · 2023 · JPGN Reports
  94. Pharmacotherapy of Obesity and Metabolic Syndrome
    Daisy Duan, Rexford S. Ahima · 2023 · Springer eBooks
  95. Prevention and Treatment of Obesity in Children
    Talia A. Hitt, Katie L. Wasserstein, Sara N. Malina, Sheela Natesh Magge · 2023 · Springer eBooks
  96. Obesity and Metabolic Syndrome in the United States
    Albert Danso Osei, Elise Tirza Ohene-Kyei, Justin Basile Echouffo-Tcheugui · 2023 · Springer eBooks
  97. After 32 Years of Action and Engagement, the European Childhood Obesity Group Keeps Fighting for the Best Prevention and Treatment of Pediatric Obesity
    Teodora Handjieva‐Darlenska, Edyta Łuszczki, Gabriel Torbahn, Caroline Braet, Susanne Ring‐Dimitriou, Elpis Athina Vlachopapadopoulou, Marie‐Laure Frelut, Margherita Caroli, Andrea Vania, Dénes Attila Molnár et al. · 2023 · Annals of Nutrition and Metabolism
  98. Adolescent Obesity in India: Need for Urgent Policy Action and Multi-sectoral Reform
    SV Madhu · 2025 · Indian Journal of Endocrinology and Metabolism
  99. Editorial: Sleeve Gastrectomy Versus Lifestyle Intervention—Redefining the Therapeutic Hierarchy for Adolescent MASLD ?
    Ilias Papadimopoulos, Frank Tacke · 2026 · Alimentary Pharmacology & Therapeutics
  100. New developments and therapies in pediatric endocrinology
    Evelien F. Gevers, Peter de Winter · 2022 · European Journal of Pediatrics